Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
45.9%
% of IHE's 38 holdings also in PJP
68.0%
% of PJP's 25 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 22.2% | 5.5% | 5.5% |
|
ELI LILLY & CO | 19.2% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 5.5% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 4.0% | 4.8% | 4.0% |
|
PFIZER INC | 4.0% | 5.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PJP
|
JOHNSON & JOHNSON | 16.7% |
|
ELI LILLY & CO | 14.7% |
|
CATALENT INC | 4.4% |
|
ZOETIS INC | 4.4% |
|
ROYALTY PHARMA PLC CLASS A | 4.1% |
|
INTRA-CELLULAR THERAPIES INC | 3.4% |
|
ELANCO ANIMAL HEALTH, INC. | 2.9% |
|
VIATRIS, INC. | 1.6% |
|
ORGANON & CO. | 1.6% |
|
AXSOME THERAPEUTICS, INC. | 1.6% |
IHE Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.0% |
|
AMGEN INC | -5.0% |
|
ABBVIE INC | -4.9% |
|
GILEAD SCIENCES INC | -3.9% |
|
REGENERON PHARMACEUTICALS | -3.7% |
|
PACIRA PHARMACEUTICALS INC | -3.6% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
CORCEPT THERAPEUTICS INC | -3.1% |
|
INNOVIVA, INC. | -3.0% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.9% |